Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.
Cell therapy CDMO BioCentriq has …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted
Roche’s TIGIT antibody tiragolumab finally scored a Phase III win following two consecutive late-stage fails last year, thanks to its SKYSCRAPER-08 trial comparing its TIGIT
Publicis Health is closing the door on a three-year opioid marketing lawsuit, paying a total of $343 million to settle the suit. The ad agency